The prevalence of metabolic syndrome in a sample of residents of Kaliningrad

Objective. To assess the prevalence of metabolic syndrome (MS) and its components in residents of Kaliningrad.

Design and methods. We examined 312 people, stratified by sex and age: 151 males (48,4 %) and 161 females (51,6 %). All subjects were interviewed using a questionnaire. Physical examination included anthropometry (waist and hip circumferences, weight, height), and blood pressure measurements. Fasting plasma lipids and glucose were assessed in all subjects (Hitachi‑902, Roche reagents). MS was defined according JIS (2009) criteria.

Results. The prevalence of hypertriglyceridemia differ significantly in men and women — 51,0 and 34,8 %, respectively (p = 0,004), the prevalence of MS was significantly higher in men compared to women in the youngest (25–34 years) age group (53,3 and 16,6 %, respectively, p = 0,003) and older (65–74 years) age group (75,9 and 46,7 %, respectively, p = 0,02). A significantly lower prevalence of MS (16,6 %) was found in women aged 25–34 compared to the age group 45–54 (63,6 %) and 55–64 years (62,2 %) (p = 0,03 and p = 0,02, respectively).

Conclusions. In a sample of residents of Kaliningrad MS and its components are highly prevalent, in particular, high prevalence of hypertriglyceridemia was found in men compared to women. Significantly higher prevalence of MS was found in in the youngest and the oldest age group of men compared to women. The prevalence of MS in women significantly increases with age, reaching maximum at the age of 45–64 years.

1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–553.

2. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of diabetes mellitus. Geneva: World Health Organization; 1999. Available from: http://apps.who.int/iris/handle/10665/66040. Accessed October26, 2015.

3. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16(5):442–443.

4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc. 2001;285 (19):2486–2497.

5. Bloomgarden ZT. American Association of Clinical Endocrinologists (AACE) Consensus Conference on the Insulin Resistance Syndrome: 25–26 August 2002, Washington, DC. Diabetes Care. 2003;26(4):933–999.

6. International Diabetes Federation. Worldwide definition of the metabolic syndrome. Available from: http://www.idf.org/webdata/docs/IDF_ Metasyndrome_definition.pdf. Accessed August 24, 2005.

7. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Executive summary. Circulation. 2005;112(17):2735–2752.

8. Alberti KGMM, Eckel HR, Grundy SM, Zimmet PZ, Cleeman JI, Karen A еt al. Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120 (16):1640–1645.

9. Козиолова Н. В., Конради А. О. Оптимизация критериев метаболического синдрома. Российский институт метаболического синдрома — согласованная позиция. Артериальная гипертензия. 2007;13(3):134–141. [Koziolova NV, Konradi AO. Optimal criteria of metabolic syndrome consensus of the Russian filial of Metabolic Syndrome Institute. Arterial’naya Gipertenziya = Arterial Hypertension. 2007;13(3):134–141. In Russian].

10. Шальнова С. А., Баланова Ю. А., Константинов В. В., Тимофеева Т. Н., Иванов В. М., Капустина А. В. и др. Артериальная гипертония: распространенность, осведомленность, прием антигипертензивных препаратов и эффективность лечения среди населения РФ. Российский кардиологический журнал. 2006;60(4):45–50. [Shal’nova SA, Balanova YA, Konstantinov VV, Timofeeva TN, Ivanov VM, Kapustina AV et al. rterial hypertension: prevalence, awareness, antihypertensivedrugs and the effectiveness of treatment in the population of the Russian Federation. Rossiyskiy Kardilogicheskiy Zhurnal = Russian Cardiology Journal. 2006;60(4):45–50. In Russian].

11. Карпов Р. С., Трубачева И. А., Перминова О. А. Популяционные аспекты сердечно-сосудистых заболеваний у взрослого населения города Томска. Кардиоваскулярная терапия и профилактика. 2004;(3):15–23. [Karpov RS, Trubacheva IA, Perminova OA. Population aspects of cardiovascular disease in the adult population of Tomsk. Kardovaskulyarnaya Terapiya i Profilaktika = Cardiovascular Therapy and Prevention. 2004; (3):15–23. In Russian].

12. Лазебник Л. Б., Гайнулин Ш. М., Дроздов В. Н., Назаренко И. В., Пятигорская С. М., Карагодина Ю. Я. Организационные мероприятия по борьбе с артериальной гипертонией в Москве. Российский медицинский журнал. 2003;(5):5–10. [Lazebnik LB, Gaynulin ShM, Drozdov VN, Nazarenko IV, Pyatigorskaya SM, Karagodina YuYa. Arrangements to combat arterial hypertension in Moscow. Rossiyskiy Medizinskiy Zhurnal = Russian Medical Journal. 2003;(5):5–10. In Russian].

13. Ротарь О. П., Либис Р. А., Исаева Е. Н., Ерина А. М., Шавшин, Д. А., Могучая Е. В. и др. Распространенность метаболического синдрома в разных городах РФ. Российский кардиологический журнал. 2012;94 (2):55–62. [Rotar OP, Libis RA, Isaeva EN, Yerina AM, Shavshin DA, Moguchaya EV et al. The prevalence of the metabolic syndrome in different cities of the Russian Federation. Rossiyskiy Kardilogicheskiy Zhurnal = Russian Cardiology Journal. 2012;94(2):55–62. In Russian].

14. Шальнова С. А., Деев А. Д. Масса тела у мужчин и женщин (результаты обследования российской, национальной, представительной выборки населения). Кардиоваскулярная терапия и профилактика. 2008;6(7):60–64. [Shalnova SA, Deev AD. Body weight in males and females (results of a survey of Russian, national, representative sample of the population). Kardovaskulyarnaya Terapiya i Profilaktika = Cardiovascular therapy and prevention. 2008;6(7):60–64. In Russian].

15. Никитин Ю. П., Казека Г. Р., Симонова Г. И. Распространенность компонентов метаболического синдрома X в неорганизованной городской популяции (эпидемиологическое исследование). Кардиология. 2001;41(9):37–40. [Nikitin YuP, Kazeka GR, Simonova GI. Prevalence of metabolic syndrome X to disorganized urban population (epidemiological study). Kardiologiia. 2001;41(9):37–40. In Russian].

16. Sidorenkov O, Nilssen O, Brenn T, Martiushov S, Arkhipovsky VL, Grjibovski AM. Prevalence of the metabolic syndrome and its components in Northwest Russia: the Arkhangelsk study. BMC Public Health. 2010;19(10):23.